aspergillomarasmine overcomes metallo-beta-lactamase antibiotic resistance 
emergence spread carbapenem-resistant gram-negative pathogens global public health problem acquisition metallo-beta-lactamases mbls ndm- principle contributor emergence carbapenem-resistant gram-negative pathogens threatens use penicillin cephalosporin carbapenem antibiotics treat infections date clinical inhibitor mbls reverse resistance re-sensitize resistant gram-negative pathogens carbapenems found identified fungal natural product aspergillomarasmine ama rapid potent inhibitor ndm- enzyme another clinically relevant mbl vim- ama also fully restored activity meropenem enterobacteriaceae acinetobacter spp pseudomonas spp possessing either vim ndm-type alleles mice infected ndm--expressing klebsiella pneumoniae ama efficiently restored meropenem activity demonstrating combination ama carbapenem antibiotic therapeutic potential address clinical challenge mbl-positive carbapenem-resistant gram-negative pathogens 
